Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S D Xiao

Showing results (11-20 of 52) with videos related to

Pageof 6
Sort By:
Alimentary Pharmacology & Therapeutics|January 19, 2007
Meta-analysis: the effect of supplementation with probiotics on eradication rates and adverse events during Helicobacter pylori eradication therapyJ L Tong, Z H Ran, J Shen, et al.
Scientific Reports|March 25, 2016
Weak, Quiet Magnetic Fields Seen in the Venus AtmosphereT L Zhang, W Baumjohann, C T Russell, et al.
Alimentary Pharmacology & Therapeutics|January 13, 2000
Does eradication of Helicobacter pylori alone heal duodenal ulcers?Z Z Ge, D Z Zhang, S D Xiao, et al.
The International Journal of Biochemistry & Cell Biology|September 12, 2001
Identification of a 70-kDa gastrin-binding protein on DLD-1 human colorectal carcinoma cellsC H Yang, J Ford, Y Karelina, et al.
Chinese Medical Journal|June 1, 1988
A model assessment of gastric precancerous lesions by morphometric analysisR N Wang, M J Zhao, B H Su, et al.
Endoscopy|September 27, 2006
The role of simeticone in small-bowel preparation for capsule endoscopyZ-Z Ge, H-Y Chen, Y-J Gao, et al.
Cell Research|January 28, 1998
A preliminary analysis of antineoplastic activity of parvovirus MVMp NS-1 proteinsX Z Shen, H C Tsung, Y W Yang, et al.
Alimentary Pharmacology & Therapeutics|April 2, 1999
High cure rate of Helicobacter pylori infection using tripotassium dicitrato bismuthate, furazolidone and clarithromycin triple therapy for 1 weekS D Xiao, W Z Liu, P J Hu, et al.
Scandinavian Journal of Gastroenterology|August 1, 1996
Seroprevalence of Helicobacter pylori infection in medical staff in ShanghaiW Z Liu, S D Xiao, S J Jiang, et al.
Alimentary Pharmacology & Therapeutics|November 9, 2000
A new quadruple therapy for Helicobacter pylori using tripotassium dicitrato bismuthate, furazolidone, josamycin and famotidineW Z Liu, S D Xiao, P J Hu, et al.
Pageof 6

Showing results (11-20 of 52) with videos related to

Sort By:
Pageof 6
Alimentary Pharmacology & Therapeutics|January 19, 2007
Meta-analysis: the effect of supplementation with probiotics on eradication rates and adverse events during Helicobacter pylori eradication therapyJ L Tong, Z H Ran, J Shen, et al.
Scientific Reports|March 25, 2016
Weak, Quiet Magnetic Fields Seen in the Venus AtmosphereT L Zhang, W Baumjohann, C T Russell, et al.
Alimentary Pharmacology & Therapeutics|January 13, 2000
Does eradication of Helicobacter pylori alone heal duodenal ulcers?Z Z Ge, D Z Zhang, S D Xiao, et al.
The International Journal of Biochemistry & Cell Biology|September 12, 2001
Identification of a 70-kDa gastrin-binding protein on DLD-1 human colorectal carcinoma cellsC H Yang, J Ford, Y Karelina, et al.
Chinese Medical Journal|June 1, 1988
A model assessment of gastric precancerous lesions by morphometric analysisR N Wang, M J Zhao, B H Su, et al.
Endoscopy|September 27, 2006
The role of simeticone in small-bowel preparation for capsule endoscopyZ-Z Ge, H-Y Chen, Y-J Gao, et al.
Cell Research|January 28, 1998
A preliminary analysis of antineoplastic activity of parvovirus MVMp NS-1 proteinsX Z Shen, H C Tsung, Y W Yang, et al.
Alimentary Pharmacology & Therapeutics|April 2, 1999
High cure rate of Helicobacter pylori infection using tripotassium dicitrato bismuthate, furazolidone and clarithromycin triple therapy for 1 weekS D Xiao, W Z Liu, P J Hu, et al.
Scandinavian Journal of Gastroenterology|August 1, 1996
Seroprevalence of Helicobacter pylori infection in medical staff in ShanghaiW Z Liu, S D Xiao, S J Jiang, et al.
Alimentary Pharmacology & Therapeutics|November 9, 2000
A new quadruple therapy for Helicobacter pylori using tripotassium dicitrato bismuthate, furazolidone, josamycin and famotidineW Z Liu, S D Xiao, P J Hu, et al.
Pageof 6